公开(公告)号：UY38837A

公开(公告)日：2021-02-26

申请号：UY38837

申请日：2020-08-13

Applicant: VERTEX PHARMA

Inventor： CLEMENS JEREMY J ,  ANDERSON COREY DON ,  CLEVELAND THOMAS ,  COON TIMOTHY RICHARD ,  FRIEMAN BRYAN ,  HADIDA RUAH SARA SABINA ,  MCCARTNEY JASON ,  MILLER MARK THOMAS ,  PARASELLI PRASUNA ,  PIERRE FABRICE ,  SWIFT SARA E ,  ZHOU JINGLAN ,  ANGELL PAUL ,  COCHRAN JOHN E ,  LITTLER BENJAMIN J ,  SIESEL DAVID ANDREW ,  URBINA ARMANDO ,  GROOTENHUIS PETER

IPC: A61P11/00 ,  C07D207/08 ,  C07D213/71 ,  C07D213/82 ,  C07D231/20 ,  C07D401/04 ,  C07D401/14 ,  C07D513/22

Abstract: La descripción proporciona procesos para sintetizar el Compuesto I, y sus sales farmacéuticamente aceptables.

公开(公告)号：LT3551622T

公开(公告)日：2021-02-25

申请号：LT17826629

申请日：2017-12-08

Applicant: VERTEX PHARMA

Inventor： ABELA ALEXANDER ,  ALCACIO TIMOTHY ,  ANDERSON COREY ,  ANGELL PAUL ,  BAEK MINSON ,  CLEMENS JEREMY ,  CLEVELAND THOMAS ,  FERRIS LORI ,  GROOTENHUIS PETER DIEDERIK ,  GROSS RAYMOND ,  GULEVICH ANTON ,  HADIDA RUAH SARA ,  HSIA CLARA ,  HUGHES ROBERT ,  JOSHI PRAMOD ,  KANG PING ,  KESHAVARZ-SHOKRI ALI ,  KHATUYA HARIPADA ,  KRENITSKY PAUL ,  MCCARTNEY JASON ,  MILLER MARK ,  PARASELLI PRASUNA ,  PIERRE FABRICE JEAN ,  SHI YI ,  SHRESTHA MUNA ,  SIESEL DAVID ,  STAVROPOULOS KATHY ,  TERMIN ANDREAS ,  UY JOHNNY ,  VAN GOOR FREDRICK ,  YOUNG TOMOTHY ,  ZHOU JINGLAN

IPC: C07D401/14 ,  A61K31/455 ,  A61P11/00 ,  C07D231/20 ,  C07D401/04

公开(公告)号：CA3150738A1

公开(公告)日：2021-02-18

申请号：CA3150738

申请日：2020-08-13

Applicant: VERTEX PHARMA

Inventor： ABELA ALEXANDER RUSSELL ,  ANDERSON COREY DON ,  BOOKSER BRETT C ,  BUSCH BRETT B ,  CLEMENS JEREMY J ,  CLEVELAND THOMAS ,  COON TIMOTHY RICHARD ,  FRIEMAN BRYAN ,  GHIRMAI SENAIT G ,  HADIDA RUAH SARA SABINA ,  ISHIHARA YOSHIHIRO ,  KHATUYA HARIPADA ,  MCCARTNEY JASON ,  MILLER MARK THOMAS ,  PARASELLI PRASUNA ,  PIERRE FABRICE ,  TERMIN ANDREAS ,  SWIFT SARA E ,  UY JOHNNY ,  VOGEL CARL V ,  ZHOU JINGLAN

IPC: A61K31/435 ,  A61P11/00 ,  C07D513/22

Abstract: This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

公开(公告)号：HRP20201946T1

公开(公告)日：2021-01-22

申请号：HRP20201946

申请日：2020-12-04

Applicant: VERTEX PHARMA

Inventor： ABELA ALEXANDER RUSSELL ,  ALCACIO TIMOTHY ,  ANDERSON COREY ,  ANGELL PAUL TIMOTHY ,  BAEK MINSON ,  CLEMENS JEREMY J ,  CLEVELAND THOMAS ,  FERRIS LORI ANN ,  GROOTENHUIS PETER DIEDERIK JAN ,  GROSS RAYMOND STANLEY ,  GULEVICH ANTON ,  HADIDA RUAH SARA SABINA ,  HSIA CLARA KUANG-JU ,  HUGHES ROBERT M ,  JOSHI PRAMOD VIRUPAX ,  KANG PING ,  KESHAVARZ-SHOKRI ALI ,  KHATUYA HARIPADA ,  KRENITSKY PAUL JOHN ,  MCCARTNEY JASON ,  MILLER MARK THOMAS ,  PARASELLI PRASUNA ,  PIERRE FABRICE JEAN DENIS ,  SHI YI ,  SHRESTHA MUNA ,  SIESEL DAVID ANDREW ,  STAVROPOULOS KATHY ,  TERMIN ANDREAS P ,  UY JOHNNY ,  VAN GOOR FREDRICK F ,  YOUNG TOMOTHY JOHN ,  ZHOU JINGLAN

IPC: C07D401/14 ,  A61K31/455 ,  A61P11/00 ,  C07D231/20 ,  C07D401/04

公开(公告)号：CR20200403A

公开(公告)日：2020-10-26

申请号：CR20200403

申请日：2019-02-14

Applicant: VERTEX PHARMA

Inventor： UY JOHNNY ,  PARASELLI PRASUNA ,  HSIA CLARA KUANG-JU ,  CLEMENS JEREMY J ,  CHEN WEICHAO GEORGE ,  MCCARTNEY JASON ,  MILLER MARK THOMAS ,  ANDERSON COREY DON ,  FRIEMAN BRYAN ,  PIERRE FABRICE ,  GULEVICH ANTON V ,  TERMIN ANDREAS ,  CLEVELAND THOMAS ,  COON TIMOTHY RICHARD ,  GHIRMAI SENAIT G ,  GROOTENHUIS PETER ,  KANG PING ,  SWIFT SARA E ,  VOGEL CARL V ,  HADIDA RUAH SARA SABINA ,  ABELA ALEXANDER RUSSELL ,  BUSCH BRETT B ,  KHATUYA HARIPADA ,  ZHOU JINGLAN

IPC: C07D515/22 ,  A61K31/437 ,  A61P11/00 ,  C07D513/22

Abstract: Se revelan compuestos de la fórmula (I): sus sales farmacéuticamente aceptables, derivados deuterados de cualquiera de los anteriores y metabolitos de cualquiera de los anteriores. También se revelan composiciones farmacéuticas que los comprenden, métodos de tratamiento de fibrosis quística que los usan y métodos para prepararlos.

公开(公告)号：TN2019000079A1

公开(公告)日：2020-07-15

申请号：TN2019000079

申请日：2017-09-29

Applicant: VERTEX PHARMA

Inventor： ABELA ALEXANDER RUSSELL ,  ALCACIO TIMOTHY ,  ANDERSON COREY ,  BAEK MINSON ,  BUSCH BRETT BRADLEY ,  CLEVELAND THOMAS ,  FRIEMAN BRYAN A ,  GROOTENHUIS PETER ,  HADIDA RUAH SARA SABINA ,  HUGHES ROBERT M ,  JOSHI PRAMOD VIRUPAX ,  KESHAVARZ-SHOKRI ALI ,  KHATUYA HARIPADA ,  KRENITSKY PAUL JOHN ,  MCAULEY-AOKI RACHEL ,  MCCARTNEY JASON ,  MELILLO VITO ,  MILLER MARK THOMAS ,  PARASELLI PRASUNA ,  PIERRE FABRICE JEAN DENIS ,  SIESEL DAVID ANDREW ,  TERMIN ANDREAS P ,  UY JOHNNY ,  VAN GOOR FREDRICK ,  ZHANG BEILI ,  ZHOU JINGLAN

IPC: A61P11/12 ,  C07D498/14

Abstract: Compounds of Formula (I), pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.

公开(公告)号：CA3123578A1

公开(公告)日：2020-05-20

申请号：CA3123578

申请日：2019-11-13

Applicant: VERTEX PHARMA

Inventor： ALTSHULER DAVID M ,  ANDERSON COREY DON ,  CHEN WEICHAO GEORGE ,  CLEMENS JEREMY J ,  CLEVELAND THOMAS ,  COON TIMOTHY RICHARD ,  FRIEMAN BRYAN ,  HADIDA RUAH SARA SABINA ,  HARE BRIAN J ,  KEWALRAMANI RESHMA ,  MCCARTNEY JASON ,  MILLER MARK THOMAS ,  PARASELLI PRASUNA ,  PIERRE FABRICE ,  ROBERTSON SARAH M ,  SOSNAY PATRICK R ,  SWIFT SARA E ,  ZHOU JINGLAN ,  BOREK BARTLOMIEJ ,  YOUNG TIM ,  VAN GOOR FREDRICK ,  GROOTENHUIS PETER

IPC: A61K31/404 ,  A61K31/47 ,  A61K45/06 ,  A61P11/00

Abstract: This application describes methods of treating cystic fibrosis or a CFTR mediated disease comprising administering Compound I or a pharmaceutically acceptable salt thereof. (I) The application also describes pharmaceutical compositions comprising Compound I or a pharmaceutically acceptable salt thereof and optionally comprising one or more additional CFTR modulating agents.

公开(公告)号：SG10201913606VA

公开(公告)日：2020-02-27

申请号：SG10201913606V

申请日：2017-12-08

Applicant: VERTEX PHARMA

Inventor： ABELA ALEXANDER ,  ALCACIO TIMOTHY ,  ANDERSON COREY ,  ANGELL PAUL ,  BAEK MINSON ,  CLEMENS JEREMY ,  CLEVELAND THOMAS ,  FERRIS LORI ,  GROOTENHUIS PETER DIEDERIK ,  GROSS RAYMOND ,  GULEVICH ANTON ,  HADIDA RUAH SARA ,  HSIA CLARA ,  HUGHES ROBERT ,  JOSHI PRAMOD ,  KANG PING ,  KESHAVARZ-SHOKRI ALI ,  KHATUYA HARIPADA ,  KRENITSKY PAUL ,  MCCARTNEY JASON ,  MILLER MARK ,  PARASELLI PRASUNA ,  PIERRE FABRICE JEAN ,  SHI YI ,  SHRESTHA MUNA ,  SIESEL DAVID ,  STAVROPOULOS KATHY ,  TERMIN ANDREAS ,  UY JOHNNY ,  VAN GOOR FREDRICK ,  YOUNG TOMOTHY ,  ZHOU JINGLAN

Abstract: Compounds of Formula (I):pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. Also disclosed are solid state forms of Compound 1 and salts and solvates thereof.

公开(公告)号：AU2017371200A1

公开(公告)日：2019-07-11

申请号：AU2017371200

申请日：2017-12-08

Applicant: VERTEX PHARMA

Inventor： ABELA ALEXANDER RUSSELL ,  ALCACIO TIMOTHY ,  ANDERSON COREY ,  ANGELL PAUL TIMOTHY ,  BAEK MINSON ,  CLEMENS JEREMY J ,  CLEVELAND THOMAS ,  FERRIS LORI ANN ,  GROOTENHUIS PETER DIEDERIK JAN ,  GROSS RAYMOND STANLEY ,  GULEVICH ANTON ,  HADIDA RUAH SARA SABINA ,  HSIA CLARA KUANG-JU ,  HUGHES ROBERT M ,  JOSHI PRAMOD VIRUPAX ,  KANG PING ,  KESHAVARZ-SHOKRI ALI ,  KHATUYA HARIPADA ,  KRENITSKY PAUL JOHN ,  MCCARTNEY JASON ,  MILLER MARK THOMAS ,  PARASELLI PRASUNA ,  PIERRE FABRICE JEAN DENIS ,  SHI YI ,  SHRESTHA MUNA ,  SIESEL DAVID ANDREW ,  STAVROPOULOS KATHY ,  TERMIN ANDREAS P ,  UY JOHNNY ,  VAN GOOR FREDRICK F ,  YOUNG TOMOTHY JOHN ,  ZHOU JINGLAN

IPC: C07D401/14 ,  A61K31/455 ,  A61P11/00 ,  C07D231/20 ,  C07D401/04

Abstract: Compounds of Formula (I) pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. Also disclosed are solid state forms of Compound 1 and salts and solvates thereof.

公开(公告)号：AU2017336156A1

公开(公告)日：2019-05-02

申请号：AU2017336156

申请日：2017-09-29

Applicant: VERTEX PHARMA

Inventor： ALCACIO TIMOTHY ,  BAEK MINSON ,  GROOTENHUIS PETER ,  HADIDA RUAH SARA SABINA ,  HUGHES ROBERT M ,  KESHAVARZ-SHOKRI ALI ,  MCAULEY-AOKI RACHEL ,  MCCARTNEY JASON ,  MILLER MARK THOMAS ,  VAN GOOR FREDRICK ,  ZHANG BEILI ,  ANDERSON COREY ,  CLEVELAND THOMAS ,  FRIEMAN BRYAN A ,  KHATUYA HARIPADA ,  JOSHI PRAMOD VIRUPAX ,  KRENITSKY PAUL JOHN ,  MELILLO VITO ,  PIERRE FABRICE JEAN DENIS ,  TERMIN ANDREAS P ,  UY JOHNNY ,  ZHOU JINGLAN ,  ABELA ALEXANDER RUSSELL ,  BUSCH BRETT BRADLEY ,  PARASELLI PRASUNA ,  SIESEL DAVID ANDREW

IPC: C07D401/14 ,  A61K31/4439 ,  A61P11/12 ,  C07D471/14 ,  C07D498/14

Abstract: Compounds of Formula (I), pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.